A Call to Clarify the Regulatory Scope of Money Transmitter Laws
The scope of state law threatens the viability of new payment systems.
CMS Proposes to Significantly Increase Reward for Reporting Medicare Fraud
CMS expects proposed rule to help recuperate more Medicare funds.
Transforming the Nature of Drug Safety Regulation
Using retrospective drug safety data can improve patient care.
Senators Question President’s Pick for OIRA Administrator
Howard Shelanski questioned on delays, retrospective review, and role for cost-benefit analysis.
Using a Compliance Cost Cap to Constrain Regulation
Forthcoming paper proposes firm limits be set on costs of regulatory policy.
TSA Seeks Comments on Whole Body Imaging at Airports
TSA will install new privacy technology on screening machines in coming weeks.
FTC Report Shows Increase in Pay-for-Delay Drug Settlements
Agency report indicates that potentially anti-competitive drug settlements are on the rise.
Institutionalizing Regulatory Lookback
Obama’s next OIRA Administrator should act to embed retrospective evaluation into the regulatory process.
Would Two Presidents be Better than One?
PPR seminar speaker makes a case for a dual presidency to break through partisan gridlock.
OMB Releases Draft of Annual Report on Regulation’s Impacts
Major rules, especially EPA’s, potentially create enormous net benefits.
Report Recommends Ways to Improve Regulatory Science
Study for ACUS examines steps agencies should take when using scientific analysis.
CFPB Possesses Unique Accountability Structure
Consumer protection agency is sensibly structured to resist the dangers of client politics.